Excited to see our work online🤩 pleased to had the chance to leverage my knowledge in #p53 in this work & honored to work with @JoeKhouryMD, our impeccable leader in this study, and amazing collaborative forces from #leukemia & #hemepath team, statisticians,& many more. a🧵

thrilled & proud of our 1st #WomenInHematology meeting! The brilliance of women in our field shone brightly. 🙏🏻 my co-chairs @LNastoupilMD @DrKrinaPatel , our amazing speakers, the team @_MDEducation & sponsors 4 making it unforgettable. Save the date for next year: Nov 7-8 2026.

Interested in learning more about the ICCS Committees? This is the topic for the next ICCS webinar which will take place on November 13 at 11:30 am ET. @ICCS_Education https://t.co/ySn0Og7oJf

We are hiring, come work with us! 🩸 🧬 🔬 🖥️ Speaking from direct experience: 10/10 recommend! 👌🏼 Pls RT @MDAndersonNews #hemepath

The College of American Pathologists is collaborating with AMP and ICCS to develop the forthcoming guideline, “Evaluation of Measurable Residual Disease (MRD) in B-Lymphoblastic Leukemia.” CAP is asking for Open Review from all ICCS members till Oct 29, 2025. Click the QR code

Bone marrow aspirate. Has anyone seen cells like this before? Who knows what these cells are? What do you think is going on? I'll post the answer in a day or two... :) #hemepath #pathx #leusm #pathology #pathtwitter

Congratulations to Shreyam Acharya (@ShreyamA), winner of the Janis Giorgi Young Investigator Award at #FlowICCS25! With ICCS President Sa Wang.

After 4 incredible years at the Univ of Minnesota, I’m thrilled to share that I’ve joined MD Anderson as a tenure-track faculty member in #Hemepath. Grateful for the amazing team I’m leaving behind and excited for this new chapter at my academic home! #EndCancer

Fret the FRET!! #flowiccs25 #iccseducation

From @SaWangMD's outstanding talk on the detection of CAR T cells by flow cytometry at #FlowICCS25 #FlowEdu #HemePath

Dr. Sa Wang navigated all aspects of CAR-T detection, excellent talk! #FlowICCS25

Targeted immunotherapy that can affect antigen detection by flow cytometry. The list keeps growing! From today's plenary session talk by Erik Ames at #FlowICCS25 #FlowEdu #HemePath

Mechanisms of CD19 loss due to CD19-directed therapies. It's important to use multiple B-cell antigens and gating strategies to avoid missing these populations. From the plenary session talk by Erik Ames at #FlowICCS25 #FlowEdu #HemePath

Daratumumab causes loss of CD38 not just on plasma cells but also on other hematopoietic cells such as hematogones and monocytes. Also watch out for pseudo kappa restriction on hematogones! From the plenary session talk by Erik Ames at #FlowICCS25 #FlowEdu #HemePath

At the Editorial Board meeting for the ICCS journal Clinical Cytometry. This is a fantastic journal for flow-related articles, so please submit your manucripts! https://t.co/nAIy5LWcJJ #FlowICCS25

And we have begun! #FlowICCS25

Dr Ajay Grover discussed LDT at ICCS 2025. Here is what he thinks each LDT document record should include. #FlowICCS25

Out today in @JCOPO_ASCO 📄 If U’r like us & often struggle w/ ddx of clonal hematopoiesis, heme malignancy, mosaic Li-Fraumeni, ctDNA, etc. we hope U find our paper helpful! Via real life cases we share our approach to diagnosis. 🧬 https://t.co/MT8btPCjO9 #hemepath #molpath

Your Monday AM #hemepath … a nice primer on PTCL, NOS classification and genetic landscape by Dr. Andy Quesada at @MDAndersonNews Pathology Grand Rounds

I just registered for #FlowICCS25, the Annual ICCS Meeting and so should you—today is the early registration deadline with a discount! I hope to see you in-person Sept 26-30, but if you can't, this is a hybrid meeting with a virtual option. Register now! https://t.co/aXxfck8HUn

Our Annual ICCS Meeting contest is back! The trainee or laboratory scientist/technologist with the highest number of tweets (using the hashtag #FlowICCS25) from today until October 15th wins 1 year of FREE ICCS membership. Tweet away! Not registered for the meeting? There's